Efficacy and safety of laparoscopic sleeve gastrectomy as a surgical treatment for obesity – initial results
Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 1
Abstract
Background. Laparoscopic sleeve gastrectomy (LSG) has recently become one of standard options of bariatric surgery. The aim of this study was to evaluate the efficacy and safety of LSG and impact of weight loss on improving in terms of co-morbidities. We report our early experience regarding to this procedure.Material and methods. A retrospective review of a prospectively maintained database of patients who underwent laparoscopic sleeve gastrectomy for obesity between January and July 2010 was conducted. Data included patient demographics, operative data, complications rates, weight loss results and co-morbidities rates before and after procedure were collected.Results. Between January and July 2010, 18 patients with obesity underwent laparoscopic sleeve gastrectomy. The mean age was 44 ± 11 years (range 25-60). The initial mean weight was 127 ± 18 kg with BMI 43.2 ± 4.4 kg/m2. The average %EWL was 40.9 ± 10.4 and average %EBMIL was 47.1 ± 13.1 at 3 months follow-up. No mortality was observed. There were no major complications. The minor complication occurred in 1 patient (5.5%) – one port site infection. The average operating time was 138.3 ± 25 min. The mean length of hospital stay was 5.5 ± 1 days. Complete remission of hypertension was observed in 11 of 18 patients (61.1%) and diabetes mellitus in 6 of 11 patients (54.5%) at 3 months follow-up.Conclusion. Proper evaluation to surgery, modification of medical treatment before the procedure and careful follow-up, especially during intensive weight loss, reduces the rates of complications after laparoscopic sleeve gastrectomy. Laparoscopic sleeve gastrectomy can be introduced with success into a center with a great experience in laparoscopic digestive surgery. Laparoscopic sleeve gastrectomy ensures a good weight loss and improved weight-related co-morbidities in short term follow-up.
Authors and Affiliations
Artur Binda, Naser Dib, Wiesław Tarnowski
Keywords
Related Articles
- EP ID EP54015
- DOI -
- Views 154
- Downloads 0
Nowe leki i ich działania niepożądane w terapii przewlekłych zapaleń wątroby typu C
Na początku lat 90. interferon rekombinowany stosowany w terapii chorych przewlekle zakażonych HCV był skuteczny u około 15% pacjentów. Skojarzenie tej terapii z rybawiryną, a następnie zastąpienie interferonu rekombinow...
Osteoporoza w przewlekłych zapaleniach stawów
Powikłania ze strony kości są typowym objawem przewlekłych zapaleń stawów. Mogą manifestować się nadżerkami kostnymi, osteoporozą miejscową i uogólnioną oraz prowadzić do zwiększonego ryzyka złamań. Według aktualnych pog...
Elevated troponin I level – a predictor of poor prognosis after ischemic stroke
Introduction. Multiple ECG abnormalities can be observed during the acute phase of ischemic stroke (IS). Right-hemisphere stroke with insular involvement is also a risk factor for cardiac complications. ECG monitoring an...
Leczenie złamań trzonu kości udowej gwoździem śródszpikowym blokowanym – omówienie sposobów ryglowania
Operacyjne leczenie złamań trzonu kości udowej opiera się na opracowanej przez Kempfa i Grosse'a technice zespolenia gwoździem śródszpikowym ryglowanym. Zespolenia gwoździem śródszpikowym ryglowanym jest stosunkowo mało...
An analysis of discrepancies between test results of the selected protein parameters and clonal bone marrow plasma cells in an assessment of treatment response in a group of patients with multiple myeloma (MM) prior to an autologous hematopoietic stem cell transplantation (AHSCT)
Introduction. Multiple myeloma (MM) is an incurable, B-cell malignancy. Modern diagnostics and disease monitoring include the assessment of serum and urine protein as well as bone marrow examination. The discrepancies of...